Literature DB >> 21228927

Phenotypic variations in NF1-associated low grade astrocytomas: possible role for increased mTOR activation in a subset.

Mark Jentoft1, Caterina Giannini, Ling Cen, Bernd W Scheithauer, Bridget Hoesley, Jann N Sarkaria, Patrice C Abell-Aleff, Erika F Rodriguez, Ying Li, Fausto J Rodriguez.   

Abstract

Low grade astrocytomas are the most common CNS tumors in neurofibromatosis type 1(NF1) patients. While most are classic pilocytic astrocytomas (PA), some are difficult to classify, and have been termed "low grade astrocytoma subtype indeterminate" (LGSI). Some of these tumors exhibit peculiar morphologies, including plump cytoplasmic processes and macronucleoli. In the current study we performed electron microscopy, followed by gene expression, immunohistochemicai and western blot analyses in an effort to identify biological differences underlying phenotypic variation in NF1-associated low grade astrocytoma. Electron microscopy demonstrated intermediate filaments and frequent Rosenthal fiber material in both PA and LGSI. Dense core granules and/or aligned microtubules were present in the LGSI group (2 of 3 cases) and in the PA group (1 of 10 cases). Analysis of global gene expression data obtained using Affymetrix HG-U133 Plus2.0 chips (5 PA, 1 LGSI), and western blot analysis for phospho-S6 (1 LGSI, 2 PA) demonstrated a gene expression profile reflecting "neuronal differentiation" and increased phospho-S6 immunoreactivity consistent with mTOR activation in the LGSI compared with PA. These findings were confirmed by immunohistochemistry for neuronal markers, as well as combined phospho-S6/ phospho-p70S6K immunoreactivity in 4 (of 4) LGSI vs. 5 (of 13) NF1-associated PA (p=0.02), and 13 (of 39) sporadic PA. Phospho-ERK immunoreactivity was uniformly present in PA and LGSI groups, while BRAF duplication was absent by FISH in 8 NF1-associated low grade astrocytomas. In summary, differential expression of neuronal-related genes and increased mTOR activation may underlie phenotypic variations in NF1-associated low grade astrocytomas.

Entities:  

Keywords:  Neurofibromatosis; astrocytoma; glioma; glioneuronal; mTOR; pilocytic astrocytoma

Mesh:

Substances:

Year:  2010        PMID: 21228927      PMCID: PMC3016103     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  23 in total

Review 1.  Control of translation by the target of rapamycin proteins.

Authors:  A C Gingras; B Raught; N Sonenberg
Journal:  Prog Mol Subcell Biol       Date:  2001

2.  An electron microscopic study of normal optic nerve and of an optic-nerve glioma.

Authors:  S A LUSE
Journal:  J Neurosurg       Date:  1961-07       Impact factor: 5.115

Review 3.  Ultrastructural pathology of glial brain tumors revisited: a review.

Authors:  P P Liberski; R Kordek
Journal:  Ultrastruct Pathol       Date:  1997 Jan-Feb       Impact factor: 1.094

4.  Immunohistochemical characterization of subependymal giant cell astrocytomas.

Authors:  M B Lopes; H J Altermatt; B W Scheithauer; C W Shepherd; S R VandenBerg
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

5.  [Electron microscopic observation of optic glioma--with special reference to the desmoplastic reaction (author's transl)].

Authors:  T Soejima; K Kitamura; M Tomonaga
Journal:  No Shinkei Geka       Date:  1974-10

Review 6.  The ultrastructural spectrum of astrocytic neoplasms.

Authors:  B W Scheithauer; J M Bruner
Journal:  Ultrastruct Pathol       Date:  1987       Impact factor: 1.094

Review 7.  Role of synaptotagmin, a Ca2+ and inositol polyphosphate binding protein, in neurotransmitter release and neurite outgrowth.

Authors:  K Mikoshiba; M Fukuda; K Ibata; H Kabayama; A Mizutani
Journal:  Chem Phys Lipids       Date:  1999-04       Impact factor: 3.329

8.  PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma.

Authors:  Erika F Rodriguez; Bernd W Scheithauer; Caterina Giannini; Amanda Rynearson; Ling Cen; Bridget Hoesley; Heather Gilmer-Flynn; Jann N Sarkaria; Sarah Jenkins; Jin Long; Fausto J Rodriguez
Journal:  Acta Neuropathol       Date:  2010-11-28       Impact factor: 17.088

9.  Glioneuronal tumours in neurofibromatosis type 1: MRI-pathological study.

Authors:  Marco Fedi; L Anne Mitchell; Renate M Kalnins; David H Gutmann; Arie Perry; Mark Newton; Amy Brodtmann; Samuel F Berkovic
Journal:  J Clin Neurosci       Date:  2004-09       Impact factor: 1.961

10.  The architecture of optic nerve gliomas with and without neurofibromatosis.

Authors:  J Stern; F A Jakobiec; E M Housepian
Journal:  Arch Ophthalmol       Date:  1980-03
View more
  16 in total

1.  Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target.

Authors:  Marianne Hütt-Cabezas; Matthias A Karajannis; David Zagzag; Smit Shah; Iren Horkayne-Szakaly; Elisabeth J Rushing; J Douglas Cameron; Deepali Jain; Charles G Eberhart; Eric H Raabe; Fausto J Rodriguez
Journal:  Neuro Oncol       Date:  2013-11-06       Impact factor: 12.300

2.  An 80-year experience with optic nerve glioma cases at the Armed Forces Institute of Pathology: evolution from museum to molecular evaluation suggests possibe interventions in the cellular senescence and microglial pathways (an American Ophthalmological Society thesis).

Authors:  J Douglas Cameron; Fausto J Rodriguez; Elisabeth Rushing; Iren Horkayne-Szakaly; Charles Eberhart
Journal:  Trans Am Ophthalmol Soc       Date:  2014

Review 3.  Targeted therapy in pediatric low-grade glioma.

Authors:  John-Paul Kilday; Ute Katharina Bartels; Eric Bouffet
Journal:  Curr Neurol Neurosci Rep       Date:  2014-04       Impact factor: 5.081

Review 4.  Advances in the management of low-grade gliomas.

Authors:  Amulya A Nageswara Rao; Roger J Packer
Journal:  Curr Oncol Rep       Date:  2014       Impact factor: 5.075

5.  Overexpression of mTOR and p(240-244)S6 in IDH1 Wild-Type Human Glioblastomas Is Predictive of Low Survival.

Authors:  Luis Eduardo Machado; Arthur William Alvarenga; Fernanda Ferreira da Silva; Martín Roffé; Maria Dirlei Begnami; Luís Fernando Bleggi Torres; Isabela Werneck da Cunha; Vilma Regina Martins; Glaucia Noeli Maroso Hajj
Journal:  J Histochem Cytochem       Date:  2018-01-12       Impact factor: 2.479

Review 6.  Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis.

Authors:  Jaishri O Blakeley; Scott R Plotkin
Journal:  Neuro Oncol       Date:  2016-02-06       Impact factor: 12.300

7.  Evaluation of Akt and RICTOR Expression Levels in Astrocytomas of All Grades.

Authors:  Arthur William Alvarenga; Luis Eduardo Machado; Bruna Roz Rodrigues; Fernanda Cristina Sulla Lupinacci; Paulo Sanemastu; Eduardo Matta; Martín Roffé; Luís Fernando Bleggi Torres; Isabela Werneck da Cunha; Vilma Regina Martins; Glaucia Noeli Maroso Hajj
Journal:  J Histochem Cytochem       Date:  2016-10-28       Impact factor: 2.479

8.  Something old and something new about molecular diagnostics in gliomas.

Authors:  Craig Horbinski
Journal:  Surg Pathol Clin       Date:  2012-12-01

Review 9.  The mTOR signaling pathway as a treatment target for intracranial neoplasms.

Authors:  Doreen Pachow; Wolfgang Wick; David H Gutmann; Christian Mawrin
Journal:  Neuro Oncol       Date:  2014-08-27       Impact factor: 12.300

Review 10.  Pathological and molecular advances in pediatric low-grade astrocytoma.

Authors:  Fausto J Rodriguez; Kah Suan Lim; Daniel Bowers; Charles G Eberhart
Journal:  Annu Rev Pathol       Date:  2012-10-29       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.